{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:20Z","timestamp":1792783160977,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Cincinnati Cancer Center","id":[{"id":"https:\/\/ror.org\/01e3m7079","id-type":"ROR","asserted-by":"crossref"}]},{"name":"University of Cincinnati Brain Tumor Center","id":[{"id":"https:\/\/ror.org\/01e3m7079","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Tufts University Medical Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05708-y","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:22:30Z","timestamp":1788452550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating ex vivo platforms with AI to guide glioblastoma treatment"],"prefix":"10.1007","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-409X","authenticated-orcid":false,"given":"Mainak","family":"Bardhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1834-2849","authenticated-orcid":false,"given":"Samanta","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2090-8804","authenticated-orcid":false,"given":"Sirjana","family":"Pun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0894-0182","authenticated-orcid":false,"given":"Manish Raj","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7790-1622","authenticated-orcid":false,"given":"Pier Paolo","family":"Claudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9813-9966","authenticated-orcid":false,"given":"Jason","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-3959","authenticated-orcid":false,"given":"Riccardo","family":"Barrile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-0786","authenticated-orcid":false,"given":"Daniel A. Pomeranz","family":"Krummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"5708_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3892\/ol.2024.14573","volume":"28","author":"T Ius","year":"2024","unstructured":"Ius T, Somma T, Pasqualetti F, Berardinelli J, Vitulli F, Caccese M et al (2024) Local therapy in glioma: An evolving paradigm from history to horizons (Review). Oncol Lett 28:440. https:\/\/doi.org\/10.3892\/ol.2024.14573 PubMed PMID: 39081966; PubMed Central PMCID: PMC11287108","journal-title":"Oncol Lett"},{"key":"5708_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. 101056\/NEJMoa043330 PubMed PMID: 15758009","journal-title":"N Engl J Med"},{"key":"5708_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/cancers17010146","volume":"17","author":"D Sipos","year":"2025","unstructured":"Sipos D, Raposa BL, Freihat O, Simon M, Mekis N, Cornacchione P et al (2025) Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes. Cancers 17:146. https:\/\/doi.org\/10.3390\/cancers17010146","journal-title":"Cancers"},{"key":"5708_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/jnen\/nlac021","volume":"81","author":"U Sahu","year":"2022","unstructured":"Sahu U, Barth RF, Otani Y, McCormack R, Kaur B (2022) Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research. J Neuropathol Exp Neurol 81:312\u2013329. https:\/\/doi.org\/10.1093\/jnen\/nlac021 PubMed PMID: 35446393; PubMed Central PMCID: PMC9113334","journal-title":"J Neuropathol Exp Neurol"},{"key":"5708_CR5","doi-asserted-by":"publisher","unstructured":"Hetze S, Sure U, Schedlowski M, Hadamitzky M, Barthel L (2021) Rodent Models to Analyze the Glioma Microenvironment. ASN Neuro 13 https:\/\/doi.org\/10.1177\/17590914211005074 PubMed PMID: 33874781; PubMed Central PMCID: PMC8060738","DOI":"10.1177\/17590914211005074"},{"key":"5708_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5114\/aoms.2016.63743","volume":"14","author":"M Kapa\u0142czy\u0144ska","year":"2018","unstructured":"Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V et al (2018) 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch Med Sci AMS 14:910\u2013919. https:\/\/doi.org\/10.5114\/aoms.2016.63743 PubMed PMID: 30002710; PubMed Central PMCID: PMC6040128","journal-title":"Arch Med Sci AMS"},{"key":"5708_CR7","doi-asserted-by":"publisher","first-page":"e201900305","DOI":"10.26508\/lsa.201900305","volume":"2","author":"VM Ravi","year":"2019","unstructured":"Ravi VM, Joseph K, Wurm J, Behringer S, Garrelfs N, d\u2019Errico P et al (2019) Human organotypic brain slice culture: a novel framework for environmental research in neuro-oncology. Life Sci Alliance 2:e201900305. https:\/\/doi.org\/10.26508\/lsa.201900305 PubMed PMID: 31249133; PubMed Central PMCID: PMC6599970","journal-title":"Life Sci Alliance"},{"key":"5708_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11912-025-01672-4","volume":"27","author":"G Thomas","year":"2025","unstructured":"Thomas G, Rahman R (2025) Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening. Curr Oncol Rep 27:601\u2013624. https:\/\/doi.org\/10.1007\/s11912-025-01672-4 PubMed PMID: 40183896; PubMed Central PMCID: PMC12081544","journal-title":"Curr Oncol Rep"},{"key":"5708_CR9","doi-asserted-by":"publisher","first-page":"e2118697119","DOI":"10.1073\/pnas.2118697119","volume":"119","author":"JP Straehla","year":"2022","unstructured":"Straehla JP, Hajal C, Safford HC, Offeddu GS, Boehnke N, Dacoba TG et al (2022) A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles. Proc Natl Acad Sci U S A 119:e2118697119. https:\/\/doi.org\/10.1073\/pnas.2118697119 PubMed PMID: 35648828; PubMed Central PMCID: PMC9191661","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5708_CR10","first-page":"2242","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Jin M, Zhao J, Chen J, Jin W (2020) Organoid models of glioblastoma: advances, applications and challenges. Am J Cancer Res 10:2242\u20132257 PubMed PMID: 32905502; PubMed Central PMCID: PMC7471358","journal-title":"Am J Cancer Res"},{"key":"5708_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.stem.2024.11.010","volume":"32","author":"M Logun","year":"2025","unstructured":"Logun M, Wang X, Sun Y, Bagley SJ, Li N, Desai A et al (2025) Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. Cell Stem Cell 32:181\u2013190e4. https:\/\/doi.org\/10.1016\/j.stem.2024.11.010 PubMed PMID: 39657679; PubMed Central PMCID: PMC11808387","journal-title":"Cell Stem Cell"},{"key":"5708_CR12","doi-asserted-by":"publisher","first-page":"588221","DOI":"10.3389\/fonc.2020.588221","volume":"10","author":"N Biswas","year":"2020","unstructured":"Biswas N, Chakrabarti S (2020) Artificial Intelligence (AI)-Based Systems Biology Approaches in Multi-Omics Data Analysis of Cancer. Front Oncol 10:588221. https:\/\/doi.org\/10.3389\/fonc.2020.588221","journal-title":"Front Oncol"},{"key":"5708_CR13","unstructured":"FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs [Internet] (2025) Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs"},{"key":"5708_CR14","unstructured":"NIH to prioritize human-based research technologies [Internet] (2025) Available from: https:\/\/www.nih.gov\/news-events\/news-releases\/nih-prioritize-human-based-research-technologies"},{"key":"5708_CR15","doi-asserted-by":"publisher","first-page":"2401876","DOI":"10.1002\/adhm.202401876","volume":"13","author":"S Pun","year":"2024","unstructured":"Pun S, Prakash A, Demaree D, Krummel DP, Scium\u00e8 G, Sengupta S et al (2024) Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma. Adv Healthc Mater 13:2401876. https:\/\/doi.org\/10.1002\/adhm.202401876","journal-title":"Adv Healthc Mater"},{"key":"5708_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/cells13040363","volume":"13","author":"B Chehri","year":"2024","unstructured":"Chehri B, Liu K, Vaseghi G, Seyfoori A, Akbari M (2024) In Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh. Cells 13:363. https:\/\/doi.org\/10.3390\/cells13040363 PubMed PMID: 38391976; PubMed Central PMCID: PMC10887613","journal-title":"Cells"},{"key":"5708_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s44222-023-00063-3","volume":"1","author":"A Loewa","year":"2023","unstructured":"Loewa A, Feng JJ, Hedtrich S (2023) Human disease models in drug development. Nat Rev Bioeng 1:545\u2013559. https:\/\/doi.org\/10.1038\/s44222-023-00063-3","journal-title":"Nat Rev Bioeng"},{"key":"5708_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41378-024-00843-w","volume":"10","author":"G Lee","year":"2024","unstructured":"Lee G, Kim SJ, Choi Y, Park J, Park JK (2024) Bioprinting of a multi-composition array to mimic intra-tumor heterogeneity of glioblastoma for drug evaluation. Microsyst Nanoeng 10:186. https:\/\/doi.org\/10.1038\/s41378-024-00843-w","journal-title":"Microsyst Nanoeng"},{"key":"5708_CR19","doi-asserted-by":"publisher","first-page":"762184","DOI":"10.3389\/fonc.2021.762184","volume":"11","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Cong L, Cong X (2021) Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank. Front Oncol 11:762184. https:\/\/doi.org\/10.3389\/fonc.2021.762184","journal-title":"Front Oncol"},{"key":"5708_CR20","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3390\/cancers13112666","volume":"13","author":"HF Cabanos","year":"2021","unstructured":"Cabanos HF, Hata AN (2021) Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer. Cancers 13:2666. https:\/\/doi.org\/10.3390\/cancers13112666","journal-title":"Cancers"},{"key":"5708_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","volume":"9","author":"J He","year":"2024","unstructured":"He J, Qiu Z, Fan J, Xie X, Sheng Q, Sui X (2024) Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies. Signal Transduct Target Ther 9:209. https:\/\/doi.org\/10.1038\/s41392-024-01891-4","journal-title":"Signal Transduct Target Ther"},{"key":"5708_CR22","doi-asserted-by":"publisher","first-page":"101025","DOI":"10.1016\/j.xcrm.2023.101025","volume":"4","author":"T Ranjan","year":"2023","unstructured":"Ranjan T, Sengupta S, Glantz MJ, Green RM, Yu A, Aregawi D et al (2023) Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial. Cell Rep Med 4:101025. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101025","journal-title":"Cell Rep Med"},{"key":"5708_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41698-025-00874-0","volume":"9","author":"TJ Herzog","year":"2025","unstructured":"Herzog TJ, Krivak TC, Bush S, Diaz JP, Lentz S, Nair N et al (2025) ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial. Npj Precis Oncol 9:86. https:\/\/doi.org\/10.1038\/s41698-025-00874-0","journal-title":"Npj Precis Oncol"},{"key":"5708_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24966\/SRDT-2060\/100076","volume":"7","author":"Department Of Biomolecular Sciences, National Center For Natural Products Research","year":"2021","unstructured":"Department Of Biomolecular Sciences, National Center For Natural Products Research (2021) University Of Mississippi, Jackson, MS 39126, United States, Claudio PP. Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer. J Stem Cells Res Dev Ther 7:1\u20139. https:\/\/doi.org\/10.24966\/SRDT-2060\/100076","journal-title":"J Stem Cells Res Dev Ther"},{"key":"5708_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijscr.2016.07.013","volume":"26","author":"A Cortese","year":"2016","unstructured":"Cortese A, Pantaleo G, Amato M, Lawrence L, Mayes V, Brown L et al (2016) A new complementary procedure for patients affected by head and neck cancer: Chemo-predictive assay. Int J Surg Case Rep 26:42\u201346. https:\/\/doi.org\/10.1016\/j.ijscr.2016.07.013","journal-title":"Int J Surg Case Rep"},{"key":"5708_CR26","unstructured":"National Cancer Institute. Researchers use AI-based modeling to assess treatment and predict survival from glioblastoma [Internet] (2025) Available from: https:\/\/www.cancer.gov\/about-nci\/organization\/cbiit\/news-events\/news\/2025\/ai-based-modeling-assess-treatment-and-predict-survival-glioblastoma"},{"key":"5708_CR27","doi-asserted-by":"publisher","first-page":"e241393","DOI":"10.1148\/radiol.241393","volume":"315","author":"HH Moon","year":"2025","unstructured":"Moon HH, Wongsawaeng Wave D, Park JE, Park SY, Baek S, Kim YH et al (2025) Maximum Resection of Noncontrast-enhanced Tumor at MRI Is a Favorable Prognostic Factor in IDH Wild-Type Glioblastoma. Radiology 315:e241393. https:\/\/doi.org\/10.1148\/radiol.241393","journal-title":"Radiology"},{"key":"5708_CR28","doi-asserted-by":"publisher","first-page":"vdaf162","DOI":"10.1093\/noajnl\/vdaf162","volume":"7","author":"A Alsaedi","year":"2025","unstructured":"Alsaedi A, Alsharif W, Gareeballah A, Alshoabi S, Alhazmi F, Alshamrani K et al (2025) Assessment of the emerging role of AI in diagnosing gliomas using MRI: Systematic review and meta-analysis. Neuro-Oncol Adv 7:vdaf162. https:\/\/doi.org\/10.1093\/noajnl\/vdaf162 PubMed PMID: 40980443; PubMed Central PMCID: PMC12448723","journal-title":"Neuro-Oncol Adv"},{"key":"5708_CR29","doi-asserted-by":"publisher","unstructured":"Smer-Barreto V, Elliott RJR, Dawson JC, Lorente-Mac\u00edas \u00c1, Unciti-Broceta A, Oyarz\u00fan DA, et al (2025) Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models [Internet]. Cancer Biology; 2025 [cited 2025 Dec 31]. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2025.03.06.641926","DOI":"10.1101\/2025.03.06.641926"},{"key":"5708_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41016-025-00399-2","volume":"11","author":"A Ron\u010devi\u0107","year":"2025","unstructured":"Ron\u010devi\u0107 A, Koruga N, Soldo Koruga A, Ron\u010devi\u0107 R (2025) Artificial Intelligence in Glioblastoma-Transforming Diagnosis and Treatment. Chin Neurosurg J 11:10. https:\/\/doi.org\/10.1186\/s41016-025-00399-2 PubMed PMID: 40457483; PubMed Central PMCID: PMC12128298","journal-title":"Chin Neurosurg J"},{"key":"5708_CR31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41746-025-01861-2","volume":"8","author":"N Tran","year":"2025","unstructured":"Tran N, Luks TL, Li Y, Jakary A, Ellison J, Liu B et al (2025) Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI. NPJ Digit Med 8:508. https:\/\/doi.org\/10.1038\/s41746-025-01861-2 PubMed PMID: 40775041; PubMed Central PMCID: PMC12331921","journal-title":"NPJ Digit Med"},{"key":"5708_CR32","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.3390\/cancers17233762","volume":"17","author":"R Master","year":"2025","unstructured":"Master R, Rubin N, Sampson J, Yadav KK, Pandita S, Sabbagh A et al (2025) Advances in Artificial Intelligence for Glioblastoma Radiotherapy Planning and Treatment. Cancers 17:3762. https:\/\/doi.org\/10.3390\/cancers17233762 PubMed PMID: 41374965; PubMed Central PMCID: PMC12691521","journal-title":"Cancers"},{"key":"5708_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/life15040643","volume":"15","author":"K Contreras","year":"2025","unstructured":"Contreras K, Velez-Varela PE, Casanova-Carvajal O, Alvarez AL, Urbano-Bojorge AL (2025) A Review of Artificial Intelligence-Based Systems for Non-Invasive Glioblastoma Diagnosis. Life 15:643. https:\/\/doi.org\/10.3390\/life15040643","journal-title":"Life"},{"key":"5708_CR34","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.1038\/s41467-025-64249-6","volume":"16","author":"J Zhao","year":"2025","unstructured":"Zhao J, Lin SY, Attias R, Mathews L, Engel C, Larghero G et al (2025) Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimics. Nat Commun 16:8341. https:\/\/doi.org\/10.1038\/s41467-025-64249-6","journal-title":"Nat Commun"},{"key":"5708_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41698-024-00575-0","volume":"8","author":"S Khalighi","year":"2024","unstructured":"Khalighi S, Reddy K, Midya A, Pandav KB, Madabhushi A, Abedalthagafi M (2024) Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment. Npj Precis Oncol 8:80. https:\/\/doi.org\/10.1038\/s41698-024-00575-0","journal-title":"Npj Precis Oncol"},{"key":"5708_CR36","doi-asserted-by":"publisher","unstructured":"Voigtlaender S, Nelson TA, Karschnia P, Vaios EJ, Kim MM, Lohmann P, et al (2025) Value of artificial intelligence in neuro-oncology. Lancet Digit Health 100876. https:\/\/doi.org\/10.1016\/j.landig.2025.100876 PubMed PMID: 40783350; PubMed Central PMCID: PMC12338051","DOI":"10.1016\/j.landig.2025.100876"},{"key":"5708_CR37","doi-asserted-by":"publisher","unstructured":"Shafana NJ, SenthilSelvi A (2021) Analysis of AI based brain tumor detection and diagnosis. in: 4th international conference on computing and communications technologies (ICCCT) [Internet]. Chennai, India: IEEE; 2021 [cited 2026 Feb 6]. pp. 627\u201333. Available from: https:\/\/ieeexplore.ieee.org\/document\/9711914\/https:\/\/doi.org\/10.1109\/ICCCT53315.2021.9711914","DOI":"10.1109\/ICCCT53315.2021.9711914"},{"key":"5708_CR38","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.3390\/app13063808","volume":"13","author":"A Aleid","year":"2023","unstructured":"Aleid A, Alhussaini K, Alanazi R, Altwaimi M, Altwijri O, Saad AS (2023) Artificial Intelligence Approach for Early Detection of Brain Tumors Using MRI Images. Appl Sci 13:3808. https:\/\/doi.org\/10.3390\/app13063808","journal-title":"Appl Sci"},{"key":"5708_CR39","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1007\/s12672-025-03303-7","volume":"16","author":"HF Tbahriti","year":"2025","unstructured":"Tbahriti HF, Boukadoum A, Benbernou M, Belhocine M (2025) Machine learning and deep learning in glioblastoma: a systematic review and meta-analysis of diagnosis, prognosis, and treatment. Discov Oncol 16:1492. https:\/\/doi.org\/10.1007\/s12672-025-03303-7","journal-title":"Discov Oncol"},{"key":"5708_CR40","doi-asserted-by":"publisher","unstructured":"Loftus TJ, Shickel B, Ruppert MM, Balch JA, Ozrazgat-Baslanti T, Tighe PJ et al (2022) Y <>Lai editor Uncertainty-aware deep learning in healthcare: A scoping review. PLOS Digit Health 1 e0000085 https:\/\/doi.org\/10.1371\/journal.pdig.0000085","DOI":"10.1371\/journal.pdig.0000085"},{"key":"5708_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH et al (2020) A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity. Cell 180:188\u2013204e22. https:\/\/doi.org\/10.1016\/j.cell.2019.11.036","journal-title":"Cell"},{"key":"5708_CR42","doi-asserted-by":"publisher","unstructured":"Farasati Far B (2023) Artificial intelligence ethics in precision oncology: balancing advancements in technology with patient privacy and autonomy. Explor Target Anti-Tumor Ther 685\u2013689. https:\/\/doi.org\/10.37349\/etat.2023.00160","DOI":"10.37349\/etat.2023.00160"},{"key":"5708_CR43","doi-asserted-by":"publisher","first-page":"100864","DOI":"10.1016\/j.landig.2025.02","volume":"7","author":"C Sad\u00e9e","year":"2025","unstructured":"Sad\u00e9e C, Testa S, Barba T, Hartmann K, Schuessler M, Thieme A et al (2025) Medical digital twins: enabling precision medicine and medical artificial intelligence. Lancet Digit Health 7:100864. https:\/\/doi.org\/10.1016\/j.landig.2025.02.004 PubMed PMID: 40518342; PubMed Central PMCID: PMC12412312","journal-title":"Lancet Digit Health"},{"key":"5708_CR44","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41568-025-00850-7","volume":"25","author":"US Asghar","year":"2025","unstructured":"Asghar US, Chung C (2025) Application of digital twins for personalized oncology. Nat Rev Cancer 25:823\u2013825. https:\/\/doi.org\/10.1038\/s41568-025-00850-7 PubMed PMID: 40634598","journal-title":"Nat Rev Cancer"},{"key":"5708_CR45","doi-asserted-by":"publisher","first-page":"e000893","DOI":"10.1136\/bmjonc-2025-000893","volume":"4","author":"M McCoy","year":"2025","unstructured":"McCoy M (2025) Digital twins in oncology: where we are and where we hope to go. BMJ Oncol 4:e000893. https:\/\/doi.org\/10.1136\/bmjonc-2025-000893 PubMed PMID: 41229611; PubMed Central PMCID: PMC12603708","journal-title":"BMJ Oncol"},{"key":"5708_CR46","doi-asserted-by":"publisher","first-page":"vbaf041","DOI":"10.1093\/bioadv\/vbaf","volume":"5","author":"Q Lyu","year":"2025","unstructured":"Lyu Q, Costen F (2025) A twin-tower model using MRI and gene for prediction on brain tumor patients\u2019 response to therapy. Bioinforma Adv 5:vbaf041. https:\/\/doi.org\/10.1093\/bioadv\/vbaf041 PubMed PMID: 40365107; PubMed Central PMCID: PMC12070387","journal-title":"Bioinforma Adv"},{"key":"5708_CR47","doi-asserted-by":"publisher","first-page":"109468","DOI":"10.1016\/j.mbs.2025.109468","volume":"387","author":"D Cerrone","year":"2025","unstructured":"Cerrone D, Riccobelli D, Gazzoni S, Vitullo P, Ballarin F, Falco J et al (2025) Patient-specific prediction of glioblastoma growth via reduced order modeling and neural networks. Math Biosci 387:109468. https:\/\/doi.org\/10.1016\/j.mbs.2025.109468 PubMed PMID: 40473100","journal-title":"Math Biosci"},{"key":"5708_CR48","doi-asserted-by":"publisher","first-page":"100529","DOI":"10.1016\/j.aimed.2025.100529","volume":"12","author":"H Khude","year":"2025","unstructured":"Khude H, Shende P (2025) AI-driven clinical decision support systems: Revolutionizing medication selection and personalized drug therapy. Adv Integr Med 12:100529. https:\/\/doi.org\/10.1016\/j.aimed.2025.100529","journal-title":"Adv Integr Med"},{"key":"5708_CR49","unstructured":"BrainStorm Health [Internet] Available from: https:\/\/myawarecoaching.substack.com\/"},{"key":"5708_CR50","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.xcrm.2023.101042","volume":"4","author":"B Mann","year":"2023","unstructured":"Mann B, Zhang X, Bell N, Adefolaju A, Thang M, Dasari R et al (2023) A living ex vivo platform for functional, personalized brain cancer diagnosis. Cell Rep Med 4:101042. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101042","journal-title":"Cell Rep Med"},{"key":"5708_CR51","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ et al (2019) An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178:835\u2013849e21. https:\/\/doi.org\/10.1016\/j.cell.2019.06.024","journal-title":"Cell"},{"key":"5708_CR52","doi-asserted-by":"publisher","first-page":"vdad152","DOI":"10.1093\/noajnl\/vdad152","volume":"5","author":"M Verduin","year":"2023","unstructured":"Verduin M, Hoosemans L, Vanmechelen M, Van Heumen M, Piepers JAF, Astuti G et al (2023) Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. Neuro-Oncol Adv 5:vdad152. https:\/\/doi.org\/10.1093\/noajnl\/vdad152","journal-title":"Neuro-Oncol Adv"},{"key":"5708_CR53","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/s42003-025-09390-0","volume":"8","author":"G Zhu","year":"2025","unstructured":"Zhu G, Shi X, Jiang Y, Zhang W, Guo L, Pei G et al (2025) Microgravity-cultured glioblastoma organoids integrated with microfluidic chip for CAR-\u03b3\u03b4 T evaluation. Commun Biol 8:1791. https:\/\/doi.org\/10.1038\/s42003-025-09390-0","journal-title":"Commun Biol"},{"key":"5708_CR54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/2159-8290.CD-21-0538","volume":"12","author":"C Kornauth","year":"2022","unstructured":"Kornauth C, Pemovska T, Vladimer GI, Bayer G, Bergmann M, Eder S et al (2022) Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders. Cancer Discov 12:372\u2013387. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0538","journal-title":"Cancer Discov"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05708-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:34:47Z","timestamp":1791358487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05708-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5708"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05708-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate, and consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.A.P.K. is a co-founder of, and holds equity in, Amlal Pharmaceuticals Inc. and is a member of its board of directors. J.B. is a co-founder of, and holds equity in, Ember Health Inc. P.P.C. is a co-founder and Chief Scientific Officer of Cordgenics, LLC, which holds the Intellectual Property rights on the ChemoID Assay platform. R.B. is an inventor on two relevant Organ Chip patents (#63\/541,038; #63\/326,569). Authors M.B., S.P., S.P., and M.R.A. declare they have no financial interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"70"}}